U

investors

With a rapidly growing business in Europe and plans for a future launch in the US, Sedana Medical is well-positioned for the future.

We are well on the way to our vision of making inhaled sedation a standard therapy in critical care.

The Share

See More

Press Releases

2026

Invitation to presentation of Sedana Medical’s interim report for the third quarter of 2026
2026-10-15 07:00
Sedana Medical AB (publ) plans to present its interim report for the third quarter of 2026 on Thursday, October 22, 2026, at 13:30 CET. According to the...
Sedana Medical’s Nomination Committee for the 2027 Annual General Meeting
2026-10-14 17:30
Regulatory
According to the principles for the appointment of the Nomination Committee in Sedana Medical AB (publ), the Nomination Committee for the Annual General...
Sedana Medical announces PDUFA target action date for its New Drug Application in the U.S.
2026-08-31 07:30
Regulatory
Sedana Medical AB (publ) today announced that the U.S. Food and Drug Administration (FDA) has set April 16, 2027 as the target action date under the Prescription...
View All Press Releases

Financial Reports

See More

Financial Calendar

See More

Latest Presentation

No presentations found.

See More